Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

B‐cell maturation antigen chimeric antigen receptor T‐cell re‐expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor‐based combination therapy

British Journal of Haematology(2021)10.1111/bjh.17397Source: DataRank Database

B‐cell maturation antigen chimeric antigen receptor T‐cell re‐expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor‐based combination therapy is a research paper published in British Journal of Haematology (2021). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

11 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: closedTopics (25)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Lifeng Tian ORCID,Alfred L. Garfall ORCID,J. Joseph Melenhorst ORCID,Simon F. Lacey ORCID,Edward A. Stadtmauer ORCID

Live enrichment

PubMed:33713436

National Institutes of Health

Grant: K12CA076931

National Cancer Institute

Grant: 1P01CA214278

American Society of Clinical Oncology

closedLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17397

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/bjh.17397

MeSH Terms

HumansMultiple MyelomaThalidomideDexamethasoneNeoplasm ProteinsAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalImmunotherapy, AdoptiveCombined Modality TherapySurvival RateAdultAgedMiddle AgedFemaleMaleB-Cell Maturation AntigenAntibodies, Monoclonal, HumanizedProgrammed Cell Death 1 ReceptorReceptors, Chimeric AntigenLenalidomideImmune Checkpoint Inhibitors

Keywords

T cellsImmunotherapyCellular TherapiesMyeloma Therapy

B‐cell maturation antigen chimeric antigen receptor T‐cell re‐expansion in a patient with myeloma following salvage programmed cell death protein 1 inhibitor‐based combination therapy

FAIR Checklist

Authors (15)

Funding (3 grants)

Open Access

Topics